MED 8710 Psychiatry Rotation Class of 2023
MED 8710 Core Experiences
Psychiatry Core Rotation
Phase 4, Class of 2023
Academic Year 2021-2022
All aspects of this assessment plan to be completed at a satisfactory level as determined by the discipline.
EPAs that can be assessed in this rotation:
EPA 1: Obtain a history and perform a physical examination adapted to the patient’s clinical situation.
EPA 2: Formulate and justify a prioritized differential diagnosis.
EPA 3: Formulate an initial plan of investigation based on the diagnostic hypotheses.
EPA 4: Interpret and communicate results of common diagnostic and screening tests.
EPA 5: Formulate, communicate and implement management plans.
EPA 6: Present oral and written reports that document a clinical encounter.
EPA 7: Provide and receive the handover in transitions of care.
EPA 8: Recognize a patient requiring urgent or emergent care, provide initial management and seek help.
EPA 9: Communicate in difficult situations.
EPA 10: Participate in health quality improvement initiatives.
EPA 12: Educate patients on disease management, health promotion and preventative medicine.
EPA 13: Collaborate as a member of an interprofessional team.
EPA 14: Incorporate the relevant social determinants of health (SDoH) and cultural safety in relation to patient’s illness and management planning.
Any of EPAs 1-13 can be assessed if requested by the learner or preceptor, or assigned in the learning plan. EPA 14 is included as a pilot and can be assessed as deemed appropriate by the learner or preceptor. Inclusion of EPA 14 in any assessments is strongly encouraged but not required.
Clinic cards (T-Res): 2 per week
Prescribed clinical experiences
Academic Half Day (AHD) attendance
Summative In-Training Assessment Report (ITAR)
Clinic card requirements by rotation:
Please note that these are the minimum required and it benefits the learner to request/record feedback at multiple opportunities to best reflect their performance.
All aspects of this assessment plan will be collated and presented at the Phase 4 Comprehensive Reviews at 6, 9, and 12 months.
Version date: April 27, 2021
Approved by SAS: April 28, 2021
Approved by UGMS: May 19, 2021